Home › Trial NCT00496808
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
- Trial IDNCT00496808
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment69
- Start date2005-03
- ConditionsDuctal Carcinoma In Situ
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.